LifeSci Capital analyst Charles Zhu initiated coverage of Crescent Biopharma (CBIO) with an Outperform rating and $22 price target
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
